Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HTR2A | P28223 | 3/20 | 0.36 |
| ▸ | HTR1A | P08908 | 1/20 | 0.36 |
| ▸ | HTR2C | P28335 | 1/20 | 0.36 |
| ▸ | HTR2B | P41595 | 1/20 | 0.36 |
| ▸ | MEN1 | O00255 | 2/20 | 0.33 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.33 |
| ▸ | MAPT | P10636 | 2/20 | 0.33 |
| ▸ | HPGD | P15428 | 2/20 | 0.33 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.33 |
| ▸ | ALOX12 | P18054 | 1/20 | 0.33 |
| ▸ | GAA | P10253 | 1/20 | 0.32 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.32 |
| ▸ | ACHE | P22303 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3739490 | 1.00 | HTR2A (0.36) | HTR2AHTR1AHTR2CHTR2BMEN1 | |
| SCHEMBL3263365 | 1.00 | HTR2A (0.36) | HTR2AHTR1AHTR2CHTR2BMEN1 | |
| SCHEMBL6271247 | 0.99 | HTR2A (0.35) | HTR2AHTR1AHTR2CHTR2BMEN1 | |
| Tetrazole SCHEMBL5145009 | 0.90 | HTR2A (0.31) | HTR2AHTR1AHTR2CHTR2B | |
| SCHEMBL6271251 | 0.88 | MEN1 (0.31) | MEN1ALDH1A1MAPTHPGDKMT2A | |
| SCHEMBL29082484 | 0.88 | HTR2A (0.34) | HTR2AHTR1AHTR2CHTR2BMEN1 | |
| SCHEMBL23488 | 0.88 | HTR2A (0.40) | HTR2AHTR1AHTR2CHTR2BALDH1A1 | |
| SCHEMBL29356973 | 0.88 | HTR2A (0.40) | HTR2AHTR1AHTR2CHTR2BALDH1A1 | |
| Phosphoric Acid SCHEMBL8156858 | 0.86 | HTR2A (0.40) | HTR2AHTR1AHTR2CHTR2BALDH1A1 | |
| Ammonia Solution, Strong SCHEMBL20492883 | 0.86 | HTR2A (0.40) | HTR2AHTR1AHTR2CHTR2BALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 287 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119776486-A | Candida chromogenic medium and preparation method and application thereof | 江门市创盛科技有限公司 | 2025-04-08 | — | — | CN | claimed |
| CN-117890357-B | Single-component color development liquid and preparation method and detection method thereof | 深圳爱信生物技术有限公司 | 2024-11-15 | — | — | CN | claimed |
| US-20240272168-A1 | IMMUNOSTAINING USING PROTEIN CONJUGATES | ADVANCED BIOSYSTEMS, INC. | 2024-08-15 | — | — | US | claimed |
| CN-117890357-A | Single-component color development liquid and preparation method and detection method thereof | 深圳爱信生物技术有限公司 | 2024-04-16 | — | — | CN | claimed |
| CN-115219718-A | Kit and method for detecting residual quantity of recombinant carboxypeptidase B in insulin aspart | 宜昌东阳光长江药业股份有限公司 | 2022-10-21 | — | — | CN | claimed |
| CN-114592031-A | Article and method for detecting aerobic bacteria | 3M创新有限公司 | 2022-06-07 | — | — | CN | claimed |
| CN-114324875-A | Cell chip and detection method and application thereof for bacterial infection | 何骏杰 | 2022-04-12 | — | — | CN | claimed |
| CN-113504363-A | Method for improving lateral chromatography sensitivity based on enzyme catalysis method | 苏州有诺真生物科技有限公司 | 2021-10-15 | — | — | CN | claimed |
| EP-3114209-B1 | ARTICLE AND METHOD FOR DETECTING AEROBIC BACTERIA | 3M INNOVATIVE PROPERTIES CO (US) | 2019-06-12 | — | — | EP | claimed |
| WO-1992008983-A1 | HIV MARKER/AIDS VACCINE | QUEEN'S UNIVERSITY AT KINGSTON (CA) | 1992-05-29 | — | — | WO | claimed |
| EP-0476930-A1 | Enzyme assays | Sankyo Company Limited (JP) | 1992-03-25 | — | — | EP | claimed |
| US-20260139240-A1 | SUBTILASE CYTOTOXIN B SUBUNIT MUTANT | GRIFFITH UNIVERSITY (AU) | 2026-05-21 | — | — | US | disclosed |
| EP-4709824-A2 | SUPERHYDROPHOBIC ANTIFOULING COATING COMPOSITIONS FOR RELEASING NITRIC OXIDE AND APPLICATIONS THEREOF | University of Georgia Research Foundation, Inc. (US) | 2026-03-18 | — | — | EP | disclosed |
| US-20260043803-A1 | MEANS FOR DETECTING SCHISTOSOMA INFECTION | ACADEMISCH ZIEKENHUIS LEIDEN (NL) | 2026-02-12 | — | — | US | disclosed |
| US-20250382385-A1 | ANTIVENOM MONOCLONAL ANTIBODIES OF RUSSELLS VIPER AND USES THEREOF | BUDDHIST TZU CHI MEDICAL FOUND (TW) | 2025-12-18 | — | — | US | disclosed |
| WO-1991004341-A1 | HDV-SPECIFIC PEPTIDES | IMCLONE SYSTEMS, INC. (US) | 1991-04-04 | — | — | WO | disclosed |
| WO-1990012594-A1 | NOVEL MONOCLONAL ANTIBODY TO NOVEL ANTIGEN ASSOCIATED WITH HUMAN TUMORS | ONCOGEN LIMITED PARTNERSHIP (US) | 1990-11-01 | — | — | WO | disclosed |
| EP-0356397-A2 | Monoclonal antibodies against, and cell surface antigen of, lung carcinoma | SANDOZ AG (CH) | 1990-02-28 | — | — | EP | disclosed |
| EP-0304663-A1 | Detection method of abnormally responding lymphocytes as well as detection reagent and kit therefor | JAPAN IMMUNO RESEARCH LABORATORIES CO., LTD. (JP) | 1989-03-01 | — | — | EP | disclosed |
| US-4687732-A | COUPLING OF MINUTE QUANITY OF SAMPLE WITH DETECTING AGENT | YALE UNIVERSITY (US) | 1987-08-18 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260139240-A1 | SUBTILASE CYTOTOXIN B SUBUNIT MUTANT | ENGASE, SPPL2B, NEU2 | HTR2A 2245/4885HTR1A 2971/4885HTR2C 2657/4885 |
| US-20260043803-A1 | MEANS FOR DETECTING SCHISTOSOMA INFECTION | CUTA, H1-10, H1-0 | HTR2A 2802/4885HTR1A 2082/4885HTR2C 2552/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.